The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(Cyclopropanecarboxamido)-4'-(piperidin-4-yl)-[1,1'-biphenyl]-3-carboxylic acid ID: ALA4483489
PubChem CID: 155540536
Max Phase: Preclinical
Molecular Formula: C22H24N2O3
Molecular Weight: 364.45
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc(NC(=O)C2CC2)cc(-c2ccc(C3CCNCC3)cc2)c1
Standard InChI: InChI=1S/C22H24N2O3/c25-21(17-5-6-17)24-20-12-18(11-19(13-20)22(26)27)15-3-1-14(2-4-15)16-7-9-23-10-8-16/h1-4,11-13,16-17,23H,5-10H2,(H,24,25)(H,26,27)
Standard InChI Key: WMNNSGJASLLONL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
34.4527 -14.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4515 -15.5950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1596 -16.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8692 -15.5945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8664 -14.7718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1578 -14.3666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1613 -16.8190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4518 -17.2268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4513 -18.0432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1594 -18.4528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8696 -18.0400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8666 -17.2249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1639 -19.2673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4549 -19.6755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4538 -20.4891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1601 -20.9007 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.8692 -20.4926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8719 -19.6728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.5726 -14.3606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2818 -14.7665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.5695 -13.5434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.7449 -14.3670 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0373 -14.7758 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3295 -14.3674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0375 -15.5930 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9207 -13.6608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5123 -14.3686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
13 14 1 0
13 18 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
10 13 1 0
5 19 1 0
19 20 2 0
19 21 1 0
1 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
26 24 1 0
27 26 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 364.45Molecular Weight (Monoisotopic): 364.1787AlogP: 3.87#Rotatable Bonds: 5Polar Surface Area: 78.43Molecular Species: ZWITTERIONHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.84CX Basic pKa: 10.07CX LogP: 0.93CX LogD: 0.93Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.75Np Likeness Score: -0.91
References 1. Zhang Z, Hao K, Li H, Lu R, Liu C, Zhou M, Li B, Meng Z, Hu Q, Jiang C.. (2019) Design, synthesis and anti-inflammatory evaluation of 3-amide benzoic acid derivatives as novel P2Y14 receptor antagonists., 181 [PMID:31376563 ] [10.1016/j.ejmech.2019.111564 ]